Dimerix Bioscience
Melbourne
Victoria
4 articles about Dimerix Bioscience
-
Dimerix Bioscience Pty Ltd Release: Recorded Interview With CEO and Rights Issue Reminder
1/16/2018
Dimerix is pleased to provide shareholders with access to a recorded interview where CEO, Kathy Harrison discusses the recent dose optimisation ASX announcement for DMX-200.
-
Dimerix Appoints Medical Advisory Board In Readiness For Phase 2b Trials
10/18/2017
Dimerix is pleased to announce the appointment of a Medical Advisory Board (MAB) to help guide the Company's DMX-200 clinical program.
-
Takeda Cambridge in Second Deal to Expand Use of Dimerix Bioscience’s GPCR-HIT Platform
4/13/2011
-
Dimerix Bioscience and Takeda Pharmaceutical Co. Ltd. Sign Agreement to Use GPCR-HIT Platform in Discovery Program
4/20/2010